Sonirid Duo

Сонирид Дуо Drug photo

The description is actual on 04.07.2016

  • Latin name: Sonirid Duo
  • ATH code: G04CA02
  • Active ingredient: Tamsulozin + Finasterid (Tamsulosinum + Finasteridum)
  • Producer: Finasterid: JSC Gideon Richter Budapest (Hungary); Tamsulozin: JSC Gideon Richter Rumyniya (Romania)

Structure

Finasterid's tablets — finasterid, magnesium stearate, talc, sodium carboxymethylstarch, gelated starch, MKTs, monohydrate of lactose, titanium dioxide, a macrogoal, monohydrate of lactose, a gipromelloz.

Tamsulozin's capsules — a tamsulozina a hydrochloride, calcium stearate, copolymer of ethyl acrylate of methacrylic acid, triethyl citrate, talc, titanium dioxide, gelatin, iron dye.

Release form

Finasterid's tablets of 5 mg in a film cover in the form of a triangle of white color, with the rounded-off ends, inodorous.

Tamsulozin's capsules of 0,4 mg in a gelatinous cover to a capsule with modified fulvous color, the size No. 2. Lid: opaque, brown color.

Set of tablets and capsules in the blister packaging on 5 pieces in a cardboard pack No. 30 and 60.

Pharmacological action

Anti-androgenic, alpha and adrenoceptor blocking.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

Tamsulozin competitively and selektivno blocks the postsynaptic adrenoceptors which are located in smooth muscles of a neck of a bladder, prostate and part of an urethra and body of a bladder that allows to lower a tone of smooth muscles of these bodies and to improve functions of a detruzor of a bladder. As a result of it the symptoms of irritation and obstruction connected with high-quality growth of ferruterous tissue of prostate gland decrease. The medical effect comes in 2 weeks of regular administration of drug. Thanks to sharp selectivity drug does not cause in patients of clinically significant change of the ABP.

Finasterid — specific inhibitor of enzyme of reductase which actively participates in transformation of testosterone in an active androgen — dihydrotestosterone (DGT). Functioning and growth of a prostate (hypertrophied fabric including), is defined directly by process of transformation of testosterone into DGT. Treatment by Finasterid for the short period reduces concentration of DGT in blood almost by 70% that promotes reduction of volume of a prostate. One-time administration of drug in a dose of 5 mg reduces concentration of DGT in blood in 24 hours by 75% which returns to initial level within 7 days.

Pharmacokinetics

Tamsulozin

It is actively soaked up in a small intestine, meal slows down absorption. Possesses high bioavailability (okolo100%). The maximum concentration in blood at a single dose is reached in 6 hours. Equilibrium concentration at a multiple dose of capsules of Tamsoluzin is reached for the fifth day, at the same time, its maximum concentration 2-3 times higher, than in case of a single dose. Communication with blood proteins high (about 99%).

Tamsulozin slowly is metabolized, biotransformation happens in a liver to formation of the active metabolites possessing selectivity to A-adrenoceptors. The considerable part of active agent is in blood in not changed look. Tamsulozin and the formed metabolites are removed by kidneys. An elimination half-life — 10-13 hours.

Finasterid

It is quickly soaked up from a gastrointestinal tract, at the same time, meal influences Finasterid's absorption does not render. Reaches the maximum concentration in blood in 2 hours. Absorption in a gastrointestinal tract after reception comes to the end in 6 hours. Finasterid's bioavailability makes about 80%.

Gets through GEB. Finasterid biotransformirutsya in a liver by oxidation to a number of metabolites. Removal happens through kidneys (about 40%) and intestines (50-60%). An elimination half-life — 6 hours.

Indications to use

Treatment of a benign hyperplasia of a prostate.

Contraindications

High sensitivity to drug, in the anamnesis postural hypotension, a renal failure, the expressed liver failure, intolerance of a galactose.

To take with caution at a liver disease, high risk of development of an uropathy, when planning operational removal of a cataract.

Women of reproductive age and especially pregnant need to avoid any contact with the crushed Finasterid's tablets and with semen of the man at which treatment there is Finasterid.

Side effects

Collateral manifestations at Tamsulozin's reception: hypersensitivity, dizziness, headache, tachycardia, postural hypotension, rhinitis, nausea, abdominal pain, vomiting, diarrhea, lock, skin itch, rash.

Collateral manifestations at Finasterid's reception: decrease in a libido, erectile dysfunction, increase in mammary glands, disturbance of an ejaculation, pain in testicles.

Sonirid Duo, application instruction (Way and dosage)

Both drugs are intended for daily reception in a dose 1 capsules of Tamsulozin and 1 tablet, Finasterida once a day after food, time is desirable in one and too. Not to chew, swallow of a capsule entirely. Drug is accepted is long. At emergence of side reactions of the patient it is necessary to transfer to mono treatment by Finasterid and to return to the combined reception mode when strengthening symptoms of DGPZh.

Overdose

There are no clinically expressed symptoms of overdose by Tamsulozin. Theoretically, in case of a single dose of a dose, therapeutic considerably exceeding, arterial hypotension can be observed.

Interaction

Joint reception of Tamsulozin with Cimetidinum can increase Tamsulozin's concentration in blood, and reception with furosemide reduces it. Warfarin and Diclofenac increase the speed of removal of Tamsulozin. Joint reception of Tamsulozin with HP for the general anesthesia or other drugs - α1-адреноблокаторами can strengthen hypotensive effect of these HP.

Terms of sale

According to the recipe.

Storage conditions

At a temperature not above 25 °C.

Period of validity

3 years.

Sonirid Duo's analogs

Drugs with similar therapeutic action: Alfinal, Cardura, Prostalamin, Dalfaz, Tamsulon, Omnik, Financial nuclear heating plant.

Zdravzona

  • Sonirid of the Duo No. 60 of a tablet and kapsulygedeon Richter
to show still
Section: Hormonal
in more detail

Education: Graduated from Sverdlovsk medical school (1968 - 1971) as "Paramedic". Graduated from the Donetsk medical institute (1975 - 1981) as "An epidemiologist, a hygienist". Passed postgraduate study in the Central scientific research institute of epidemiology Moscow (1986 - 1989). An academic degree – the candidate of medical sciences (degree is awarded in 1989, protection – the Central scientific research institute of epidemiology Moscow). Numerous advanced training courses are studied in epidemiology and infectious diseases.

Experience: Work as the manager of department of disinfection and sterilization of 1981 - 1992. Work as the manager of department of especially dangerous infections of 1992 - 2010. Teaching activity at Medical institute 2010 - 2013.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Sonirid Duo surely consult with the attending physician.